Company profile for Advaite Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ADVAITE Inc. is a biotech company focused on developing novel therapeutics and diagnostics to help patients suffering from a variety of debilitating diseases, primarily within the oncology space. The word ‘Advaite’ means ‘one without a second’, unrivaled or unique. At ADVAITE, we aspire to be just that. ADVAITE is housed within the University of Illinois Incubator Laboratory facility which serves as a home to both life...
ADVAITE Inc. is a biotech company focused on developing novel therapeutics and diagnostics to help patients suffering from a variety of debilitating diseases, primarily within the oncology space. The word ‘Advaite’ means ‘one without a second’, unrivaled or unique. At ADVAITE, we aspire to be just that. ADVAITE is housed within the University of Illinois Incubator Laboratory facility which serves as a home to both life science and engineering firms at various stages of development within a vibrant entrepreneurial ecosystem that leverages University assets.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2242 W Harrison St Mailbox 201-2 Chicago, IL 60612
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2021/06/29/2254903/0/en/BGI-announces-strategic-US-partnership-with-Advaite-launches-diagnostics-partnership-forum.html

GLOBENEWSWIRE
29 Jun 2021

https://advaite.com/press-release/advaite-inc-enters-into-exclusive-license-option-agreement-with-the-george-washington-university-for-novel-ames-negative-hdac6-inhibitor-technology/

PRESS RELEASE
10 Dec 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty